Literature DB >> 7671167

Altered osteoblast gluconeogenesis in X-linked hypophosphatemic mice is associated with a depressed intracellular pH.

L Rifas1, A Gupta, K A Hruska, L V Avioli.   

Abstract

We have studied gluconeogenesis and intracellular pH levels in normal (+/Y) and X-linked hypophosphatemic (Hyp/Y) mice. Compared with +/Y littermates, Hyp/Y mouse osteoblasts showed a higher rate of glucose production from fructose (10-fold), glutamine, and malate, but no significant difference when alpha-ketoglutarate was used as substrate. The activities of the pentose cycle enzymes, glucose-6-phosphate dehydrogenase, and 6-phosphogluconate dehydrogenase, were not different in the two osteoblast preparations. Examination of intracellular pH (pHi) using the double excitation of the pH-sensitive dye 2',7'-bis(2-carboxyethyl)-5(6)-carboxyfluorescein acetoxymethyl ester (BCECF-AM) revealed a significantly lower pHi in Hyp/Y mouse osteoblasts compared with +/Y mouse osteoblasts (7.01 +/- 0.03 n = 10 versus 7.15 +/- 0.04 n = 8, respectively; P < 0.05). These results show for the first time that osteoblasts are capable of glucose production and that glucose production is altered in the Hyp/Y mouse osteoblast. As altered gluconeogenesis has been associated with reduced intracellular pH in other systems, a similar mechanism may be operative in the Hyp/Y mouse osteoblast. The observed defects may be intrinsic to the Hyp phenotype as the alterations in intracellular pH and gluconeogenesis persisted in vitro, or they may represent impressed memory from the in vivo state and the presumed circulating factor that influences phosphate transport.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7671167     DOI: 10.1007/bf00298998

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  25 in total

1.  Phosphorylation of the C-terminal domain of the Na+/H+ exchanger by Ca2+/calmodulin-dependent protein kinase II.

Authors:  L Fliegel; M P Walsh; D Singh; C Wong; A Barr
Journal:  Biochem J       Date:  1992-02-15       Impact factor: 3.857

2.  Characterization of the defect in the Na(+)-phosphate transporter in vitamin D-resistant hypophosphatemic mice.

Authors:  N Nakagawa; N Arab; F K Ghishan
Journal:  J Biol Chem       Date:  1991-07-25       Impact factor: 5.157

3.  pH regulation in single glomerular mesangial cells. I. Acid extrusion in absence and presence of HCO3-.

Authors:  G Boyarsky; M B Ganz; R B Sterzel; W F Boron
Journal:  Am J Physiol       Date:  1988-12

4.  Phosphate transport by osteoblasts from X-linked hypophosphatemic mice.

Authors:  B Ecarot; J Caverzasio; M Desbarats; J P Bonjour; F H Glorieux
Journal:  Am J Physiol       Date:  1994-01

5.  Phosphate transport in osteoblasts from normal and X-linked hypophosphatemic mice.

Authors:  L Rifas; L L Dawson; L R Halstead; M Roberts; L V Avioli
Journal:  Calcif Tissue Int       Date:  1994-06       Impact factor: 4.333

6.  Cytosolic pH regulation in osteoblasts. Regulation of anion exchange by intracellular pH and Ca2+ ions.

Authors:  J Green; D T Yamaguchi; C R Kleeman; S Muallem
Journal:  J Gen Physiol       Date:  1990-01       Impact factor: 4.086

7.  Primary cultures of renal epithelial cells from X-linked hypophosphatemic (Hyp) mice express defects in phosphate transport and vitamin D metabolism.

Authors:  C L Bell; H S Tenenhouse; C R Scriver
Journal:  Am J Hum Genet       Date:  1988-09       Impact factor: 11.025

8.  Defective bone formation by transplanted Hyp mouse bone cells into normal mice.

Authors:  B Ecarot-Charrier; F H Glorieux; R Travers; M Desbarats; F Bouchard; A Hinek
Journal:  Endocrinology       Date:  1988-08       Impact factor: 4.736

9.  Protein kinase C in mouse kidney: effect of the Hyp mutation and phosphate deprivation.

Authors:  A Boneh; H S Tenenhouse
Journal:  Kidney Int       Date:  1990-02       Impact factor: 10.612

10.  Effect of dietary phosphate deprivation and supplementation of recipient mice on bone formation by transplanted cells from normal and X-linked hypophosphatemic mice.

Authors:  B Ecarot; F H Glorieux; M Desbarats; R Travers; L Labelle
Journal:  J Bone Miner Res       Date:  1992-05       Impact factor: 6.741

View more
  12 in total

Review 1.  The molecular background to hypophosphataemic rickets.

Authors:  P S Rowe
Journal:  Arch Dis Child       Date:  2000-09       Impact factor: 3.791

2.  Gestational exposure to ethanol suppresses msx2 expression in developing mouse embryos.

Authors:  L Rifas; D A Towler; L V Avioli
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

3.  Correction of the mineralization defect in hyp mice treated with protease inhibitors CA074 and pepstatin.

Authors:  Peter S N Rowe; Naoko Matsumoto; Oak D Jo; Remi N J Shih; Jeannine Oconnor; Martine P Roudier; Steve Bain; Shiguang Liu; Jody Harrison; Norimoto Yanagawa
Journal:  Bone       Date:  2006-06-09       Impact factor: 4.398

Review 4.  Regulation of bone-renal mineral and energy metabolism: the PHEX, FGF23, DMP1, MEPE ASARM pathway.

Authors:  Peter S N Rowe
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2012       Impact factor: 1.807

5.  Dietary P(i) deprivation in rats affects liver cAMP, glycogen, key steps of gluconeogenesis and glucose production.

Authors:  W Xie; T L Tran; D T Finegood; G van de Werve
Journal:  Biochem J       Date:  2000-11-15       Impact factor: 3.857

6.  SPR4-peptide alters bone metabolism of normal and HYP mice.

Authors:  Lesya V Zelenchuk; Anne-Marie Hedge; Peter S N Rowe
Journal:  Bone       Date:  2014-11-22       Impact factor: 4.398

7.  Pex/PEX tissue distribution and evidence for a deletion in the 3' region of the Pex gene in X-linked hypophosphatemic mice.

Authors:  L Beck; Y Soumounou; J Martel; G Krishnamurthy; C Gauthier; C G Goodyer; H S Tenenhouse
Journal:  J Clin Invest       Date:  1997-03-15       Impact factor: 14.808

Review 8.  The wrickkened pathways of FGF23, MEPE and PHEX.

Authors:  Peter S N Rowe
Journal:  Crit Rev Oral Biol Med       Date:  2004-09-01

9.  MEPE has the properties of an osteoblastic phosphatonin and minhibin.

Authors:  P S N Rowe; Y Kumagai; G Gutierrez; I R Garrett; R Blacher; D Rosen; J Cundy; S Navvab; D Chen; M K Drezner; L D Quarles; G R Mundy
Journal:  Bone       Date:  2004-02       Impact factor: 4.398

Review 10.  The chicken or the egg: PHEX, FGF23 and SIBLINGs unscrambled.

Authors:  Peter S N Rowe
Journal:  Cell Biochem Funct       Date:  2012-05-09       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.